AntiPlatelet theraPy stratEgy followiNg Left Atrial appenDAGe closurE
NCT: NCT04796714 · RECRUITING
Brief Summary
The APPENDAGE study is a phase 4 multicentre randomized opened clinical trial comparing 2 different antithrombotic strategies following left atrial appendage closure (LAAC) in patients with non valvular atrial fibrillation (AF). The primary objective of the study is to evaluate the efficacy of Aspirin versus Aspirin + Clopidogrel after LAAC by comparing the occurrence of ischemic lesions on cerebrovascular magnetic resonance imaging (MRI) studies.
Frequently Asked Questions
What is AntiPlatelet theraPy stratEgy followiNg Left Atrial appenDAGe closurE?
AntiPlatelet theraPy stratEgy followiNg Left Atrial appenDAGe closurE is a clinical trial registered under NCT04796714. Current status: RECRUITING.
What is the status of NCT04796714?
The current status of NCT04796714 (AntiPlatelet theraPy stratEgy followiNg Left Atrial appenDAGe closurE) is: RECRUITING.
When did AntiPlatelet theraPy stratEgy followiNg Left Atrial appenDAGe closurE start?
AntiPlatelet theraPy stratEgy followiNg Left Atrial appenDAGe closurE started on 2022-10-03.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.